DP
David Parrot
DELAYED 1 MONTH
Chief Financial Officer
Scribe Therapeutics, Inc.
Filings
1
Companies
1
Latest
Mar 13, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
70
SCTXCLUSTER 2
Scribe Therapeutics, Inc.
David Parrot
Chief Financial Officer
Purchase
$40.0K
2,666 sh
Jul 28 1:20 AM
Jul 23, 2026